SERVICES
We help digital life science companies turn data into evidence into impact.
DIGITAL HEALTH SCIENTIFIC COMMUNICATIONS STRATEGY
"Extraordinary claims require extraordinary evidence." Clinicians, investors, and payers demand peer-reviewed proof in digital health, but the academic pace of publishing is far too slow for innovative startups.
Let us support you to build a portfolio of peer-reviewed data, editorials, and B2B marketing content to establish credibility in the marketplace while showcasing how you are pushing your field forward.
BUILDING A PIPELINE OF SCIENTIFIC EVIDENCE
We offer a scalable, science-driven analysis of your current positioning — with actionable insights to sharpen your advantage.
Start by assessing your scientific footprint in the literature and see how it stacks up to your competitors, alongside an audit of your current capabilities. Next we analyze the fastest leverage points and develop priorities for your strategic focus. Finally, we identify the quick wins, upgrade your processes and infrastructure, and start managing your SciComms pipeline proactively to achieve your business objectives.
MEASURING WHAT MATTERS
Patient-generated Health Data (PGHD) and Patient-reported outcomes (PROs) are a key part of your digital health tool, letting your users track their progress over time, identify key trends, and even self-experiment. We can identify validated tools and approaches that can measure what matters to patients, clinicians, researchers, and other stakeholders at scale.
PAUL WICKS, PHD.
Paul is a neuropsychologist and expert in digital health, clinical trials, and patient centricity. For 13 years he led the R&D team at PatientsLikeMe, an online community for over 850,000 people living with medical conditions. Specialising in clinical research using the Internet, Paul shaped the scientific validity of the platform in generating insights from patient-generated health data, and has published over 200 studies including a patient-driven observational trial of lithium in ALS, numerous patient-reported outcome measures, a “dose-response” curve for the benefits of friendship between patients, and methods for patient-centered and virtual clinical trial designs.
He has sat on the editorial boards of the BMJ, BMC Medicine, JMIR, Digital Biomarkers, The Patient, and BMJ Digital Health & AI. Prior to joining PatientsLikeMe, Paul worked at the Institute of Psychiatry (King’s College London) studying cognition and neuroimaging in ALS, with a postdoc in psychological consequences of Parkinson’s disease.
His work has been profiled by the BBC, NPR, CNN, BBC Radio 4, the Wall Street Journal, and the New York Times. In 2011 he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award, recognized as a TED Fellow in 2012, and joined the inaugural FLIER Program at the Academy of Medical Sciences in 2019.
SELECTED CLIENTS
ADA HEALTH
Supporting better health outcomes and clinical excellence with intelligent technology.
ASTRAZENECA
Driven by innovative science to deliver life-changing medicines to millions of people worldwide
COREVITAS
The Built-for-Purpose Provider of Gold-Standard Real-World Evidence
HAPPIFY
Build Skills for Lasting Happiness
LINDUS HEALTH
Faster, More Reliable Clinical Trials
.png)
SANO GENETICS
Health Research Made Personal
WOEBOT
Tiny Conversations to Feel Your Best
THE WELLCOME TRUST
Science to solve the urgent health challenges facing everyone
THREAD RESEARCH
The Industry Leader in Decentralized Trials
SPEAKING
From keynotes described as "the highlight of the conference" to corporate workshops, we can offer transformative talks on digital innovation, inspirational citizen science, and the future of health. Paul has spoken on global stages including TED, Lift!, and the G8, and spoken for corporate clients in finance, life sciences, and consulting.
